JPMorgan analyst Lisa C. Gill reiterated an Overweight rating and $20.00 price target on Privia Health Group Inc (NASDAQ: PRVA)The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Privia Health Group Inc (PRVA) PT Lowered to $28 at Truist SecuritiesFebruary 29, 2024 5:50 AM Privia Health Group, Inc. (PRVA) Tops Q4 EPS by 11c, provides guidanceFebruary 27, 2024 6:15 AM Form 8-K Privia Health Group, For: Feb 27February 27, 2024 6:06 AM Privia Health Reports Fourth Quarter and Full-Year 2023 Financial ResultsFebruary 27, 2024 6:00 AM Jefferies Assumes Privia Health Group Inc (PRVA) at Buy, 'demonstrated ability in driving value for physician partners'February 25, 2024 10:54 PM